1naresh2naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

    [519867d9-683f-4e0e-81ba-a0169c722b17] => Array
        (
            [runtime-id] => 519867d9-683f-4e0e-81ba-a0169c722b17
            [type] => toll-free-key
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [92cb0759-0da8-43a7-b027-aae2870a1d39] => Array
                        (
                            [runtime-id] => 92cb0759-0da8-43a7-b027-aae2870a1d39
                            [type] => toll-free-key
                        )

                )

            [credentials] => Array
                (
                    [method] => toll-free-key
                    [value] => tf_ipsecsha;5f4bb8b3453e6eb809988bc99641e75a60ae4203
                )

        )

)
1naresh2naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => FreeToRead
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

    [293c837b-1733-4710-ae25-3c242a9f78a8] => Array
        (
            [runtime-id] => 293c837b-1733-4710-ae25-3c242a9f78a8
            [type] => toll-free-key
            [service-id] => ajnr-ac.highwire.org
            [access-type] => FreeToRead
            [privilege] => Array
                (
                    [16bfc3ca-30fa-4441-83c7-0dfa884197c1] => Array
                        (
                            [runtime-id] => 16bfc3ca-30fa-4441-83c7-0dfa884197c1
                            [type] => toll-free-key
                        )

                )

            [credentials] => Array
                (
                    [method] => toll-free-key
                    [value] => tf_ipsecsha;5f4bb8b3453e6eb809988bc99641e75a60ae4203
                )

        )

)
PT  - JOURNAL ARTICLE
AU  - Baba, Akira
AU  - Kurokawa, Ryo
AU  - Kurokawa, Mariko
AU  - Yanagisawa, Takafumi
AU  - Srinivasan, Ashok
TI  - Performance of Neck Imaging Reporting and Data System (NI-RADS) for Diagnosis of Recurrence of Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-analysis
AID  - 10.3174/ajnr.A7992
DP  - 2023 Sep 14
TA  - American Journal of Neuroradiology
4099  - http://www.ajnr.org/content/early/2023/09/14/ajnr.A7992.short
4100  - http://www.ajnr.org/content/early/2023/09/14/ajnr.A7992.full
AB  - BACKGROUND: The Neck Imaging Reporting and Data System (NI-RADS) is a reporting template used in head and neck cancer posttreatment follow-up imaging.PURPOSE: Our aim was to evaluate the pooled detection rates of the recurrence of head and neck squamous cell carcinoma based on each NI-RADS category and to compare the diagnostic accuracy between NI-RADS 2 and 3 cutoffs.DATA SOURCES: The MEDLINE, Scopus, and EMBASE databases were searched.STUDY SELECTION: This systematic review identified 7 studies with a total of 694 patients (1233 lesions) that were eligible for the meta-analysis.DATA ANALYSIS: The meta-analysis of pooled recurrence detection rate estimates for each NI-RADS category and the diagnostic accuracy of recurrence with NI-RADS 3 or 2 as the cutoff was performed.DATA SYNTHESIS: The estimated recurrence rates in each category for primary lesions were 74.4% for NI-RADS 3, 29.0% for NI-RADS 2, and 4.2% for NI-RADS 1. The estimated recurrence rates in each category for cervical lymph nodes were 73.3% for NI-RADS 3, 14.3% for NI-RADS 2, and 3.5% for NI-RADS 1. The area under the curve of the summary receiver operating characteristic for recurrence detection with NI-RADS 3 as the cutoff was 0.887 and 0.983, respectively, higher than 0.869 and 0.919 for the primary sites and cervical lymph nodes, respectively, with NI-RADS 2 as the cutoff.LIMITATIONS: Given the heterogeneity of the data of the studies, the conclusions should be interpreted with caution.CONCLUSIONS: This meta-analysis revealed estimated recurrence rates for each NI-RADS category for primary lesions and cervical lymph nodes and showed that NI-RADS 3 has a high diagnostic performance for detecting recurrence.AUCarea under the curveCE-CTcontrast-enhanced CTCE-MRIcontrast-enhanced MRIDORdiagnostic odds ratioNI-RADSNeck Imaging Reporting and Data SystemsROCsummary receiver operating characteristic